drugset / Trial / NCT06304805
TGRX-326 Pharmacokinetic Food Effect Bioavailability Study
Phase 1
Completed
24 enrolled
Shenzhen TargetRx Co., Ltd.
The First Affiliated Hospital of Bengbu Medical University · collab
RandomizedCrossoverSingle-blindTreatment
Summary
A study evaluating the effects of food intake on the pharmacokinetic (PK) profiles of TGRX-326 and the effect of different drug specifications on human bioavailability for TGRX-326, a drug indicated for non-small cell lung cancer treatment
Timeline
- Start
- 2023-12-13
- Primary completion
- 2024-01-12
- Completion
- 2024-01-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TGRX-326 | Unknown | 60 mg | Oral |